X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16046) 16046
Book Chapter (348) 348
Newspaper Article (295) 295
Newsletter (268) 268
Book / eBook (11) 11
Book Review (11) 11
Publication (9) 9
Dissertation (8) 8
Trade Publication Article (3) 3
Transcript (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (14154) 14154
humans (11317) 11317
index medicus (9586) 9586
radiotherapy (8902) 8902
male (6525) 6525
cancer (6413) 6413
female (6365) 6365
middle aged (6305) 6305
aged (6020) 6020
care and treatment (4562) 4562
radiology, nuclear medicine & medical imaging (4414) 4414
chemotherapy (4378) 4378
adult (4265) 4265
hematology, oncology and palliative medicine (4241) 4241
radiation-therapy (4034) 4034
radiation therapy (3641) 3641
medicine & public health (3516) 3516
research (3034) 3034
surgery (3032) 3032
treatment outcome (3024) 3024
radiation (2993) 2993
aged, 80 and over (2959) 2959
radiology (2688) 2688
radiotherapy dosage (2584) 2584
patients (2566) 2566
survival (2534) 2534
prognosis (2426) 2426
retrospective studies (2366) 2366
neoplasm staging (2182) 2182
combined modality therapy (2143) 2143
toxicity (2117) 2117
prostate cancer (1966) 1966
metastasis (1962) 1962
carcinoma (1949) 1949
analysis (1940) 1940
cancer therapies (1893) 1893
tumors (1793) 1793
follow-up studies (1725) 1725
health aspects (1656) 1656
therapy (1542) 1542
survival rate (1521) 1521
irradiation (1507) 1507
randomized-trial (1414) 1414
chemoradiotherapy (1409) 1409
disease-free survival (1407) 1407
trial (1354) 1354
oncology, experimental (1330) 1330
clinical trials (1329) 1329
prostatic neoplasms - radiotherapy (1326) 1326
squamous-cell carcinoma (1308) 1308
breast cancer (1257) 1257
antineoplastic combined chemotherapy protocols - therapeutic use (1250) 1250
survival analysis (1240) 1240
risk factors (1228) 1228
neoplasms. tumors. oncology. including cancer and carcinogens (1222) 1222
patient outcomes (1199) 1199
lung cancer (1167) 1167
radiology and nuclear medicine (1121) 1121
prospective studies (1039) 1039
cisplatin (1010) 1010
dose fractionation (1000) 1000
usage (985) 985
radiosurgery (971) 971
cancer research (969) 969
brachytherapy (963) 963
intensity-modulated radiotherapy (955) 955
quality of life (955) 955
nuclear radiation (919) 919
lung neoplasms - pathology (900) 900
head and neck cancer (893) 893
brain neoplasms - secondary (889) 889
radiotherapy, intensity-modulated - methods (887) 887
metastases (885) 885
quality-of-life (878) 878
surgical oncology (873) 873
cancer patients (853) 853
chemoradiation (851) 851
lung neoplasms - radiotherapy (850) 850
diagnosis (848) 848
medical prognosis (848) 848
neoplasms (841) 841
multivariate analysis (840) 840
lung cancer, non-small cell (832) 832
squamous cell carcinoma (819) 819
phase-iii trial (804) 804
radiotherapy planning, computer-assisted - methods (802) 802
antineoplastic agents - therapeutic use (790) 790
head (782) 782
breast neoplasms - radiotherapy (779) 779
risk (772) 772
brain neoplasms - radiotherapy (760) 760
kaplan-meier estimate (754) 754
medical research (753) 753
carcinoma, squamous cell - radiotherapy (745) 745
imrt (741) 741
radiology nuclear medicine and imaging (728) 728
head and neck neoplasms - radiotherapy (715) 715
young adult (714) 714
brain metastases (708) 708
carcinoma, squamous cell - pathology (707) 707
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16635) 16635
German (243) 243
French (86) 86
Spanish (24) 24
Italian (13) 13
Japanese (12) 12
Polish (10) 10
Chinese (9) 9
Russian (3) 3
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2011, Volume 103, Issue 19, pp. 1452 - 1460
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared with TRT alone has been shown to confer a survival advantage for good... 
IRRADIATION | CARBOPLATIN | CISPLATIN | VINORELBINE | ONCOLOGY | THERAPY-ONCOLOGY-GROUP | CHEMORADIOTHERAPY | RADIOTHERAPY | CHEMOTHERAPY | RADIATION-THERAPY | PACLITAXEL | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | United States | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Time Factors | Vinblastine - adverse effects | Aged, 80 and over | Adult | Dose Fractionation | Chemotherapy, Adjuvant | Odds Ratio | Radiotherapy, Adjuvant | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Etoposide - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Disease Progression | Canada | Confounding Factors (Epidemiology) | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Etoposide | Research | Lung cancer, Non-small cell | Drug therapy | Radiotherapy | Health aspects | Index Medicus
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 09/2016, Volume 108, Issue 9
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 77 - 84
Purpose To determine the effect of dose and fractionation schedule of prophylactic cranial irradiation (PCI) on the incidence of chronic neurotoxicity (CNt)... 
Radiology | Hematology, Oncology and Palliative Medicine | Limited-disease small-cell lung cancer | Prophylactic cranial irradiation | Neuropsychological testing | Chronic neurotoxicity | Quality of life | LONG-TERM SURVIVORS | TEST-RETEST | COMPLETE REMISSION | COMPLETE RESPONSE | FOLLOW-UP | CHEMOTHERAPY | ONCOLOGY | CLINICAL-TRIALS | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | PSYCHOMETRIC VALIDATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lung Neoplasms - drug therapy | Follow-Up Studies | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Brain - radiation effects | Cranial Irradiation | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - secondary | Brain Neoplasms - prevention & control | Neuropsychological Tests | Small Cell Lung Carcinoma - prevention & control | Regression Analysis | Small Cell Lung Carcinoma - radiotherapy | Aged, 80 and over | Quality of Life | Adult | Dose Fractionation | Female | Aged | Chronic Disease | Care and treatment | Cancer patients | Analysis | Lung cancer | Radiation | Clinical trials | Radiotherapy | Index Medicus | NEOPLASMS | STATISTICS | LUNGS | RADIATION DOSES | STANDARD OF LIVING | MEDICINE | NUCLEAR MEDICINE | MATHEMATICS | IRRADIATION | ORGANS | DISEASES | THERAPY | DOSES | RESPIRATORY SYSTEM | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | RADIOTHERAPY | BODY | RADIOLOGY | HAZARDS | SCHEDULES | neuropsychological testing | prophylactic cranial irradiation | Limited disease small cell lung cancer | chronic neurotoxicity | quality of life
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2014, Volume 32, Issue 27, pp. 2940 - 2950
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 1, pp. 56 - 62
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 2, pp. 294 - 302
...). Radiation Therapy Oncology Group 9902 was a randomized trial testing the hypothesis that adjuvant combination chemotherapy (CT... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | DEPRIVATION | ORAL ETOPOSIDE | GROUP PROTOCOL 92-02 | RADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | III TRIAL | DURATION | ESTRAMUSTINE | PACLITAXEL | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Neoplasm Grading | Time Factors | Chemotherapy, Adjuvant - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Etoposide - therapeutic use | Paclitaxel - therapeutic use | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Androgen Antagonists - therapeutic use | Aged | Combined Modality Therapy - methods | Estramustine - therapeutic use | Clinical trials | Radiotherapy | Health aspects | Adjuvant treatment | Radiation | Cancer | Index Medicus | PROSTATE | LUTEINIZING HORMONE | PATIENTS | NEOPLASMS | CLINICAL TRIALS | FAILURES | METASTASES | ANTIGENS | TOXICITY | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | LIBERINS | INHIBITION | DATA | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | ANDROGENS
Journal Article
Journal of neurosurgery, ISSN 1933-0693, 2018, Volume 129, Issue 1, pp. 35 - 47
OBJECTIVE This is the first clinical outcomes report of NRG Oncology RTOG 0539, detailing the primary endpoint, 3-year progression-free survival (PFS... 
Oncology | Radiotherapy | WHO Grade II (atypical) | Meningioma | meningioma | SURGERY | GROSS-TOTAL RESECTION | INTRACRANIAL MENINGIOMAS | PROGNOSTIC-FACTORS | ATYPICAL MENINGIOMAS | oncology | CLINICAL NEUROLOGY | RADIATION-THERAPY | radiotherapy | POSTOPERATIVE IRRADIATION | GRADE | RECURRENCE
Journal Article
Journal Article